|
시장보고서
상품코드
2076286
치열 치료 시장 : 치료법별, 투여 경로별, 유통 채널별, 지역별Anal Fissure Treatment Market, By Treatment Type, By Route of Administration, By Distribution Channel, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
치열 치료 시장은 2026년에 12억 1,550만 달러 규모에 달할 것으로 추정되며, 2033년까지 17억 6,810만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 5.5%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 12억 1,550만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간의 CAGR: | 5.50% | 2033년 시장 규모 예측: | 17억 6,810만 달러 |
치열은 전 세계적으로 많은 사람이 앓고 있는 흔한 질환입니다. 이는 항문 점막에 생기는 작은 찢어짐이나 베인 상처를 말하며, 배변 시 불편감이나 통증, 경우에 따라 출혈을 유발합니다. 치열은 저절로 치유되기도 하지만, 증상을 완화하고 치유를 촉진하기 위해서는 대부분의 경우 치료가 필요합니다.
대부분의 치열은 몇 주 안에 저절로 치유되지만, 치유되지 않는 경우에는 합병증이 발생할 가능성이 있습니다. 이를 만성 치열이라고 합니다. 치유되기는커녕 악순환에 빠져 상처가 더욱 악화되어, 낫지 않는 상처로 남게 됩니다.
치열의 증상으로는 배변 시 통증, 배변 후 몇 시간 동안 지속되는 통증, 배변 후 대변이나 화장지에 묻어나는 선홍색 혈액, 항문 주변 피부에 눈에 띄는 갈라진 자국, 치열 부근 피부에 생기는 작은 혹이나 피부 돌기 등이 있습니다.
전 세계 치열 유병률이 증가함에 따라, 전 세계 치열 치료 시장은 눈부신 성장을 이루고 있습니다. 앉아 있는 시간이 많은 생활 습관, 부적절한 식습관, 고령화의 진행과 같은 요인들이 치열의 발생률 증가에 기여하고 있습니다. 또한, 다양한 치료법 선택지가 있다는 인식이 높아지고, 최소침습 수술에 대한 수요가 증가함에 따라 시장 성장이 더욱 가속화되고 있습니다.
시장 역학:
전 세계 치열 유병률의 증가와 시장 참여자들의 신제품 출시 증가가 예측 기간 동안 시장 성장을 견인할 것으로 예상됩니다. 예를 들어, 2022년 9월 15일 'Clinical Medicine'지에 발표된 자료에 따르면, 뉴멕시코주 일반 인구의 연간 치열 발병률은 0.11%인 것으로 나타났습니다.
본 조사의 주요 특징:
- 본 조사에서는 2025년을 기준 연도로 하여, 2026년부터 2033년까지의 예측 기간 동안의 시장 규모 및 연평균 성장률(CAGR, %)을 포함하여 전 세계 치열 치료 시장에 대한 종합적인 분석을 제공합니다.
- 본 보고서는 다양한 부문에서 잠재적인 수익 기회를 밝혀내고, 이 시장을 대상으로 한 매력적인 투자 제안 매트릭스를 제시하고 있습니다.
- 또한, 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 또한, 전 세계 치열 치료 시장의 주요 기업 개요도 수록되어 있으며, 각 기업의 배경, 제품 포트폴리오, 재무 실적 및 전략이 강조되어 있습니다.
- 본 조사에서 다룬 주요 기업으로는 Abvie, Novartis AG, Teva Pharmaceuticals, Troikaa, RDD Pharma, Ltd, Kyowa Kirin Co., Ltd, Cipla Inc., Ipsen Pharma, Sanofi, Boehringer Ingelheim International GmbH, Bliss GVS, SRS Life Sciences, Healthy Life Pharma Private Limited, and Geri-Care Pharmaceuticals Corp이 포함됩니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 제품 출시, 시장 확대 및 마케팅 전략과 관련하여 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 세계 치열 치료 시장에 관한 본 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 애널리스트 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 치열 치료 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 정보에 기반한 의사결정을 내릴 수 있습니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계 각국의 치열 치료
제5장 세계의 치열 치료 시장 : 치료 유형별, 2021-2033년
제6장 세계의 치열 치료 시장 : 투여 경로별, 2021-2033년
제7장 세계의 치열 치료 시장 : 유통 채널별, 2021-2033년
제8장 세계의 치열 치료 시장 : 지역별, 2021-2033년
제9장 경쟁 구도
제10장 섹션
KSM 26.07.07Anal Fissure Treatment Market is estimated to be valued at USD 1,215.5 Mn in 2026 and is expected to reach USD 1,768.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,215.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.50% | 2033 Value Projection: | USD 1,768.1 Mn |
Anal fissure is a common medical condition that affects a significant number of individuals worldwide. It refers to a small tear or cut in the lining of the anus, resulting in discomfort, pain, and sometimes bleeding during bowel movements. While anal fissures can heal on their own, it often require treatment to alleviate symptoms and promote healing.
Many anal fissures heal by themselves in a few weeks, but complications can develop when they don't. These are called chronic anal fissures. Instead of healing, they continue to reinforce themselves in a vicious cycle, leaving a persistent wound.
Symptoms of anal fissure includes; Pain during bowel movements, Pain after bowel movements that can last up to several hours, Bright red blood on the stool or toilet paper after a bowel movement, a visible crack in the skin around the anus, a small lump or skin tag on the skin near the anal fissure
Global anal fissure treatment market is witnessing significant growth due to increasing prevalence of anal fissures globally. Factors such as sedentary lifestyles, poor dietary habits, and rising aging population contribute to growing incidence of anal fissures. Rising awareness about the availability of various treatment options and increasing demand for minimally invasive procedures are further driving the market growth.
Market Dynamics:
Increasing prevalence of anal fissure globally and increasing product launches by the market players are expected to aid drive the market growth over the forecast period. For instance, on September 15, 2022, according to the data published by the Clinical Medicine, annual incidence of anal fissures in the general population is 0.11% in New Mexico.
Key Features of the Study:
- This study provides a comprehensive analysis of the global anal fissure treatment market, including market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period of 2026-2033, with 2025 as the base year
- The report elucidates potential revenue opportunities across different segments and offers attractive investment proposition matrices for this market
- It provides key insights into market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- The profiles of key players in the global anal fissure treatment market are included, highlighting their company background, product portfolio, financial performance, and strategies
- Key companies covered in this study include Abvie, Novartis AG, Teva Pharmaceuticals, Troikaa, RDD Pharma, Ltd, Kyowa Kirin Co., Ltd, Cipla Inc., Ipsen Pharma, Sanofi, Boehringer Ingelheim International GmbH, Bliss GVS, SRS Life Sciences, Healthy Life Pharma Private Limited, and Geri-Care Pharmaceuticals Corp
- The insights from this report enable marketers and management authorities of companies to make informed decisions regarding product launches, market expansion, and marketing tactics
- Global anal fissure treatment market report caters to various stakeholders in the industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders can make informed decisions through different strategy matrices used in analyzing the global anal fissure treatment market
Anal Fissure Treatment Market Detailed Segmentation:
- By Treatment Type (Revenue, USD Mn, 2021 - 2033)
- Laxatives
- Topical Nitrates
- Calcium Channel Blockers
- Stool Softeners
- Surgery
- Others
- By Route of Administration (Revenue, USD Mn, 2021 - 2033)
- Oral
- Topical
- Others
- By Distribution Channel (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top companies in Global Anal Fissure Treatment Market
- Abvie
- Novartis AG
- Teva Pharmaceuticals
- Troikaa
- RDD Pharma, Ltd
- Kyowa Kirin Co., Ltd
- Cipla Inc.
- Ipsen Pharma
- Sanofi
- Boehringer Ingelheim International GmbH.
- Bliss GVS
- SRS Life Sciences
- Healthy Life Pharma Private Limited
- Geri-Care Pharmaceuticals Corp.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Anal Fissure Treatment Market, By Treatment Type
- Anal Fissure Treatment Market, By Route of Administration
- Anal Fissure Treatment Market, By Distribution Channel
- Anal Fissure Treatment Market, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Increasing Prevalence of Anal Fissures
- Rising Awareness and Removing Social Stigma
- Restraints
- Social Taboo Inhibiting Treatment Seeking
- Product Recall
- Opportunities
- Huge Scope in Emerging Economies
- Growing Demand for Minimally Invasive Procedures
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Merger and Acquisition Scenario
4. Global Anal Fissure Treatment
- Supply Side and Demand Side Analysis
- Economic Impact
5. Global Anal Fissure Treatment Market, By Treatment Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
- Laxatives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Topical Nitrates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Calcium Channel Blockers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Stool Softeners
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
6. Global Anal Fissure Treatment Market, By Route of Administration, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€" 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
7. Global Anal Fissure Treatment Market, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€" 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Mn)
8. Global Anal Fissure Treatment Market, By Region, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2022-2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Mn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Abbvie
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Teva Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Troikaa
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- RDD Pharma, Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Kyowa Kirin Co., Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Cipla Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ipsen Pharma
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Boehringer Ingelheim International GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bliss GVS
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SRS Life Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Healthy Life Pharma Private Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Geri-Care Pharmaceuticals Corp
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
10. Section
- Research Methodology
- About us
